Generic

Saltica 50/250 contains Salmeterol and Fluticasone Propionate, a combination of a long-acting β2-agonist and an inhaled corticosteroid.

Description

Saltica 50/250 is an inhalation capsule by Renata Pharma Ltd., designed for the regular treatment of asthma and COPD in patients requiring a long-acting β2-agonist and corticosteroid therapy.

Benefits

Saltica 50/250 provides sustained bronchodilation and anti-inflammatory action, reducing asthma symptoms, preventing exacerbations, and improving overall lung function for better respiratory health.

Ingredients

The active ingredients in Saltica 50/250 are Salmeterol 50 mcg and Fluticasone Propionate 250 mcg per dose.

Uses and Doses

Saltica 50/250 is used for managing asthma and COPD.

• Adults and adolescents (12 years and older): One inhalation capsule twice daily.
• Pediatric patients (4-11 years): One inhalation capsule containing Salmeterol 50 mcg and Fluticasone Propionate 100 mcg twice daily.
  For COPD, the recommended dose is one inhalation capsule of Salmeterol 50 mcg and Fluticasone Propionate 250 mcg twice daily. Rinsing the mouth after use is advised to prevent side effects.

Side Effects

Common side effects include tremors, palpitations, hoarseness, headache, and oral candidiasis. Rarely, it may cause paradoxical bronchospasm, hypersensitivity reactions, or systemic corticosteroid effects like adrenal suppression or growth retardation in children.

How to Use

Remove the inhalation capsule from its blister just before use. Please place it in the inhaler device, pierce the capsule as instructed, and inhale the powder deeply. Rinse your mouth with water after each use to prevent oral fungal infections.

Pregnancy & Lactation

Saltica 50/250 should be used during pregnancy or breastfeeding only if the potential benefits outweigh the risks. Salmeterol and Fluticasone Propionate plasma levels are low after inhalation, making systemic transfer minimal.

Precautions and Warnings

Do not use Saltica 50/250 for acute asthma attacks or during exacerbations. It may cause paradoxical bronchospasm, requiring immediate discontinuation. Use cautiously in patients with cardiovascular conditions, diabetes, or severe asthma. Monitor for pneumonia symptoms in COPD patients and systemic corticosteroid effects with prolonged use.

Safety Information

Saltica 50/250 is contraindicated in patients with hypersensitivity to its components and is not for acute asthma episodes. Keep it out of children’s reach and store it as per guidelines.

Indications

Saltica 50/250 is indicated for the regular treatment of asthma and COPD, particularly in patients requiring combination therapy with a long-acting β2-agonist and inhaled corticosteroid.

Pharmacology

Salmeterol provides long-acting bronchodilation by selectively targeting β2-adrenoceptors, while Fluticasone Propionate reduces inflammation and prevents asthma exacerbations by acting as a potent glucocorticoid.

Therapeutic Class

Saltica 50/250 belongs to the class of long-acting β2-agonists and respiratory corticosteroids.

Storage Conditions

Store below 30°C, away from direct sunlight and heat. Keep out of children’s reach and avoid puncturing or burning the pressurized canister.

3 FAQ

1. Can Saltica 50/250 be used for acute asthma attacks?
   No, it is not for immediate relief. Use a fast-acting bronchodilator for acute attacks.
2. How often should Saltica 50/250 be used?
   Typically, it is used twice daily or as prescribed by a doctor.
3. Why should I rinse my mouth after using Saltica 50/250?
   Rinsing helps prevent oral fungal infections caused by the corticosteroid component.

Disclaimer

Always consult a healthcare provider before use. Use Saltica 50/250 only as prescribed and follow medical guidance.

Keywords: Saltica 50/250, Salmeterol, Fluticasone Propionate, asthma management, COPD treatment, long-acting β2 agonist, inhaled corticosteroid, asthma control, Renata Pharma, bronchodilator, Fluticasone benefits, combination inhaler, respiratory health, inhaler therapy, asthma relief, corticosteroid inhaler, airway management, COPD exacerbation prevention, respiratory medication, bronchodilator uses.